MTOR and neoplasm: Earlier studies have reported an enhanced cellular overgrowth upon clonal loss of tumor suppressors of the phosphatidylinositol 3-kinase (PI3K)/Akt/mechanistic target of rapamycin (mTORC1) signaling network.